<?xml version="1.0" encoding="UTF-8"?>
<results title="country">
 <result pre="aerosol formulation of aprotinin has been developed and approved in" exact="Russia" post="for the treatment of mild-to-moderate influenza infections (Zhirnov et"/>
 <result pre="731 nM and 569 nM, respectively (Basak and Lotfipour 2005)." exact="Turkey" post="ovomucoid third domain (OMTKY3) belongs to the family of"/>
</results>
